Insitro Patents – Insights & Stats

Insitro has a total of 29 patents globally, out of which 3 have been granted. Of these 29 patents, more than 86% patents are active. The United States of America is where Insitro has filed the maximum number of patents, followed by Canada and Europe. Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Insitro.

Insitro was founded in the year 2018 by Daphne Koller. The company operates as a data-driven drug discovery and development company. The Company leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

Do read about some of the most popular patents of Insitro which have been covered by us in this article and also you can find Insitro patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Insitro patent portfolio.

How many patents does the founder and the CEO of Insitro have?

The founder and CEO Daphne Koller has 8 patents.

How many patents does Insitro have?

Insitro has a total of 29 patents globally. These patents belong to 10 unique patent families. Out of 29 patents, 25 patents are active.

How Many Patents did Insitro File Every Year?

Insitro Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantInsitro Applications FiledInsitro Patents Granted
202242
202181
20205
20188
20174

How many Insitro patents are Alive/Dead?

Insitro Patents Portfolio

How Many Patents did Insitro File in Different Countries?

Insitro Worldwide Patents

Countries in which Insitro Filed Patents

CountryPatents
United States Of America8
Canada4
Europe4
India2
China2
Australia1

Where are the Research Centres of Insitro Patents Located?

The Research Centre for all the Insitro patents is the United States of America.

What Percentage of Insitro US Patent Applications were Granted?

Insitro (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Insitro patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Insitro?

Law FirmTotal ApplicationsSuccess Rate
Morrison & Foerster3100.00%
Goodwin Procter20%

List of Insitro Patents

Insitro PatentsTitle
US11423256B2Biological Image Transformation Using Machine-Learning Models
US11186836B2Oligonucleotide Directed And Recorded Combinatorial Synthesis Of Encoded Probe Molecules
US20220358331A1Biological Image Transformation Using Machine-Learning Models
US20220154179A1Oligonucleotide Directed And Recorded Combinitorial Synthesis Of Encoded Probe Molecules
US20220145362A1Methods And Systems For Processing Or Analyzing Oligonucleotide Encoded Molecules
US20210366577A1Predicting Disease Outcomes Using Machine Learned Models
US20200332441A1Molecules For Verifying Oligonucleotide Directed Combinatorial Synthesis And Methods Of Making And Using The Same
US20200263163A1Multinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
EP3938566A4Methods And Systems For Processing Or Analyzing Oligonucleotide Encoded Molecules
EP3688156A4Multinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
EP3619340A4Molecules For Verifying Oligonucleotide Directed Combinatorial Synthesis And Methods Of Making And Using The Same
EP3472376A4Oligonucleotide Directed And Recorded Combinatorial Synthesis Of Encoded Probe Molecules
CN109312492BOligonucleotide-Directed And Recorded Combinatorial Synthesis Of Encoded Probe Molecules
CN111295444AMultinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
WO2022266658A1Methods Of Preparing Bivalent Molecules
WO2022261241A1Predicting Cellular Pluripotency Using Contrast Images
WO2022178522A1Synthetic Barcoding Of Cell Line Background Genetics
WO2022055903A3Biological Image Transformation Using Machine-Learning Models
WO2021237117A1Predicting Disease Outcomes Using Machine Learned Models
WO2020186174A1Methods And Systems For Processing Or Analyzing Oligonucleotide Encoded Molecules
WO2019060856A1Multinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
WO2018204420A1Molecules For Verifying Oligonucleotide Directed Combinatorial Synthesis And Methods Of Making And Using The Same
CA3178602A1Predicting Disease Outcomes Using Machine Learned Models
CA3131890A1Methods And Systems For Processing Or Analyzing Oligonucleotide Encoded Molecules
CA3076755A1Multinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
CA3024875A1Oligonucleotide Directed And Recorded Combinatorial Synthesis Of Encoded Probe Molecules
IN202117043426AMethods And Systems For Processing Or Analyzing Oligonucleotide Encoded Molecules
IN202017016079AMultinomial Encoding For Oligonucleotide-Directed Combinatorial Chemistry
AU2021275995A1Predicting Disease Outcomes Using Machine Learned Models

What are Insitro’s key innovation segments?

What Technologies are Covered by Insitro?

The chart below distributes patents filed by Insitro in different countries on the basis of the technology protected in patents. It also represents the markets where Insitro thinks it’s important to protect particular technology inventions.

R&D Focus: How has Insitro’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Insitro?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.